The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...

The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...

During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...

Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

Another gene therapy death of a Duchenne patient has some parents and doctors criticizing the FDA's actions, even as other ...

A conversation with Kathryn Edwards, a physician and expert in childhood respiratory diseases and vaccine safety, on RFK ...

If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ ...

Why did RFK Jr. abruptly fire all members of CDC's vaccine advisory panel? Vaccine expert Kathryn Edwards joins the podcast ...

A new agreement between the FDA and Avidity Biosciences could further assuage industry concerns about the agency’s stance on ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

May was a terrible month for biotech, but June is (early days) looking better.